Recent e-mails have reminded me just how many newly diagnosed patients and/or caregivers log-on to this site each and every day. Keeping this in mind, I thought it was time to bring back my "Back to Basics" series, designed to help bring our new readers up to speed.One question: What is induction therapy? According to
Here is a clinical summary about the new myeloma drug I wrote about last night, perifosine, from a Website named "drugdevelopment-technology.com:"KRX-0401 (perifosine) is a potential oral anti-cancer agent that suppresses the pathways associated with the programmed growth, death, differentiation and survival of cells. Developed by Keryx, the drug is most effective in modulating Akt, as
I met lots of interesting patients and caregivers at last weeks IMF conference on multiple myeloma. For example, Friday evening I sat with Janet and David Koenig who had traveled all of the way from Gretna, Nebraska. Janet was diagnosed about 40 months ago and is currently enrolled in a study using Thalidomide and Zometa.